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Sequencing of phosphoserine-containing peptides yields normally no identifiable PTH-derivatives at those 
positions where phosphoserine is located. Here a new method is described which allows identification of 
the position of phosphoserine by chemical modification just before sequence analysis. In a one-step micro- 
batch reaction, phosphoserine present in the intact peptide can be transformed quantitatively into stable 
derivatives such as b-methylaminoalanine (MAA), S-ethanolcysteine or S-ethylcysteine. These derivatives 
are detectable during microsequencing with less than 100 pmol peptide using an Applied Biosystems gas- 
phase sequencer equipped with an on-line PTH amino acid analyzer. 
Phosphoserine derivatization Sequence analysis Phosphopeptide 
p-Methylaminoalanine 
S-Ethylcysteine S-Ethanolcysteine 
1. INTRODUCTION 
In eukaryotes, protein phosphorylation- 
dephosphorylation is one of the most important 
mechanisms for regulation of many intracellular 
functions [ 11. Until now there have been many dif- 
ficulties in localization of a phosphorylated 
residue. The strategy often employed consists of 
splitting such a phosphoprotein or peptide into 
small pieces. Then the amino acid composition 
rather than the amino acid sequence is used to 
identify the phosphorylated residue [2-41. To 
overcome such difficulties Simpson et al. [5] have 
suggested transforming phosphoserine into cysteic 
acid and, alternatively, Kolesnikova et al. [6] into 
fl-methylaminoalanine (MAA) by &elimination 
and subsequent sulfite or methylamine addition, 
respectively. Clark and Dijkstra [7] improved the 
method by using dimethylamine or methylmercap- 
tan as reagents for addition. With the latter thiol 
substitution the amino acid sequence of phosvitin, 
a protein exceptionally rich in phosphoserine, was 
established [8]. 
We have now succeeded in performing a one- 
step modification reaction allowing easy microse- 
quencing of less than 100 pmol of a peptide con- 
taining phosphoserine. 
2. MATERIALS AND METHODS 
Kemptide (LRRASLG) was obtained from Ser- 
va. Ethanol was from Baker, dimethyl sulfoxide 
from Merck, methylamine from Linde and 
dithiothreitol (DTT) from Sigma. Acetonitrile, 
NaOH and mercaptoethanol were from Roth. 
Trifluoroacetic acid ahd ethanethiol were pur- 
chased from Pierce. Phenylisothiocyanate (PITC) 
was from Beckman. All reagents for sequence 
analysis were from Applied Biosystems. All other 
chemicals or solvents were of the highest purity 
available. 
[y-32P]ATP was prepared according to Walseth 
and Johnson [9]. The catalytic subunit of the 
CAMP-dependent protein kinase was prepared ac- 
cording to Beavo et al. [lo]. Phospho-Kemptide 
was prepared by incubation of 2OOpg Kemptide 
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(260 nmol) in 5 mM magnesium acetate, 40 mM 
potassium phosphate, 7.5% glycerol, 0.1 mM 
dithiothreitol, 23 pug protein kinase (catalytical 
subunit) and 1 mM ATP containing 5 x 10’ cpm 
[y-32P]ATP at pH 7.3 and 26°C for 30 min in a 
total volume of 4.1 ml [l 11. 
Phospho-Kemptide was purified by reverse- 
phase HPLC using an 8 x 50 mm column filled 
with Vydac 218TP 5u material. 
The phosphoserine residue was modified as 
follows: 1 nmol phospho-Kemptide was dried in a 
screw cap test tube (14 x 100 mm, Corning) and 
solubilized in 50~1 of the different modification 
mixtures. These consisted of 60~1 of either 10 M 
methylamine (freshly prepared from a gas con- 
tainer), or mercaptoethanol, or ethanethiol and 
200~1 water, 200 ,J dimethyl sulfoxide, 80 ,J 
ethangl and 65 ~1 of 5 N NaOH. The addition of 
organic solvents protects the peptide from destruc- 
tion [ 121. These mixtures were incubated for 1 h at 
50°C under nitrogen, the tubes then cooled and 
10 ~1 acetic acid added. An aliquot of each mixture 
was directly analyzed in the gas-phase sequencer. 
Amino acid analysis was done by reverse-phase 
HPLC using precolumn modification with PITC 
[13,14]. 
Sequence analysis was performed on an Applied 
Biosystems gas-phase sequencer equipped with an 
on-line PTH amino acid analyzer, using the 03 
RPTH program. 
3. RESULTS AND DISCUSSION 
Kemptide, one of the best small peptide 
substrates for CAMP-dependent protein kinase 
[ll], was taken as a model peptide in this study. 
Phospho-Kemptide can easily be separated from 
the unphosphorylated peptide by reverse-phase 
HPLC as shown in fig.1. After purification both 
Kemptide and phospho-Kemptide were taken for 
subsequent experiments. 
Fig.2 shows the PTH-chromatograms of all 7 
degradation steps of Kemptide. It is clearly seen 
that the serine residue in cycle 5 yields two 
products, PTH-serine and the DTT adduct 
thereof. Under the conditions employed the peak 
area ratio is 25:75, as can be seen in fig.2. The 
same results were obtained when Kemptide was 
subjected to the modification conditions for 
phospho-Kemptide, demonstrating that the un- 
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Fig.1. 5.5 nmol Kemptide and 7 nmol phospho- 
Kemptide were separated on a reverse-phase HPLC 
column and eluted with a gradient consisting of 0.1% 
trifluoroacetic acid in water (A) and 0.08% 
trifluoroacetic acid in 84% acetonitrile/l6% water (B) at 
a flow rate of 3 ml/min. 
modified serine is not affected during the treat- 
ment with different modification mixtures (not 
shown). Upon Edman degradation of unmodified 
phospho-Kemptide, surprisingly, almost 100% of 
the phosphoserine in cycle 5 yields the DTT adduct 
of PTH-serine (fig.3). The ratio between the two 
possible PTH derivatives emerging from an un- 
modified serine during Edman degradation, as 
shown above, depends on the program used and 
other parameters of the gas-phase sequencer. An 
observed shift of this ratio towards the DTT ad- 
duct is therefore only unambiguously indicative of 
phosphoserine in our sequencer and under our 
conditions as given in section 2 (note given by Ap- 
plied Biosystems). To establish a general procedure 
we have modified phospho-Kemptide with three 
different modification mixtures. Phosphoserine 
was converted into either MAA, S-ethanolcysteine 
or S-ethylcysteine by P-elimination and subsequent 
addition of either methylamine, mercaptoethanol 
or ethanethiol, respectively. Fig.4 shows the result 
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Fig.2. Sequence analysis of 120 pm01 Kemptide. 
of sequence analysis of the S-ethanoicysteine- 
containing Kemptide. The PTH derivative of 9 
ethanolcysteine lutes with the same retention time 
as the DTT adduct of PTH-serine [15]. 
Analogous chromatograms of the sequence 
analysis of MAA-Ke~pt~de are shown in fig.5 
PTH-MAA is detected in cycle 5 as a peak eluting 
just behind PTH-tryptophan as confirmed with 
Fig.3. Sequence analysis of 100 pmol phospho- 
Kemptide. 
synthetic PTH-MAA, which was kindly provided 
by Dr Annan [f6]. In fig.6 the results of Edman 
degradation of the ~-ethylcystei~e-~odjfied 
Kemptide are shown. The PTH derivative of S- 
ethylcysteine appears as a well-separated narrow 
peak just before the elution position of DPTU. 
This elution position is in agreement with the 
PTH-amino acid analysis of this derivative as 
63 
Volume 204, number 1 FEBS LETTERS August 1986 
Fig.4. Sequence analysis of 130 pmol S-ethanolcysteine 
(S-EtOH-C)Kemptide. 
reported by Pavlik and Kosta [15]. Some of the 
DTT adduct of PTH-serine can also be seen, 
resulting from partial &elimination and 
dithiothreitol addition which occurs during con- 
version to the PTH derivative inside the conversion 
flask. However, this amount never exceeds 20% of 
the peak area of the PTH-S-ethylcysteine, 
Of the different modi~cation methods studied 
Fig.5. Sequence analysis of 150 pmol MAA-Kemptide. 
here, the transformation of phosphoserine to S- 
ethylcysteine seems to be best. All the others also 
work but the DTT and mercaptoethanol adducts 
of serine emerge at the same elution position, 
precluding definite identification of a phos- 
phoserine residue. PTH-MAA yields a weil- 
separated peak in the chromatogram. However, 
the introduction of MAA results in the incorpora- 
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Fig,& Sequence analysis of 120 pmol S-ethylcysteine (S- 
Et-C)Kemptide. 
tion of a phenylthiocarbamyl residue into the & 
amino group. Thereafter the peptide exhibits a 
more hydrophobic character following the first 
degradation step which lowers the repetitive yield 
due to enhanced wash out (see fig.5). Therefore the 
addition of ethanethiol following ~-elimination of 
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Fig.7, PTC-amino acid analysis of Kemptide and MAA- 
Kemptide. The PTC-amino acids were separated on a 
Beckman Ultrasphere ODS 5u column (4.6 x 250 mm) 
at 40°C and a flow rate of 1 ml/min. A gradient of 
160 mM potassium acetate, pH 5.2, vs 84% acetonitrile 
was applied. 
the phosphate group is the best choice out of the 
series shown. It also seems to be better suited than 
methylmercaptan, as suggested by Clark and 
Dijkstra [7], since liquid. ethanethiol is safer to 
handle than gaseous methylmercaptan. 
A suggested modification reaction is also 
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suitable for the determination of phosphoserine 
residues during amino acid analysis [17]. Fig.7 
shows the results of the phenylthiocarbamyl-amino 
acid analysis of Kemptide and MAA-Kemptide. 
The sensitivity for the MAA derivative is similar to 
that of the other amino acid derivatives and deter- 
mination of phosphoserine residues at the 
picomolar level is possible. It is a much more sen- 
sitive method than phosphate analysis [18], which 
requires at least 1 nmol phosphate for one 
determination. 
A limitation to all three modification methods is 
a possible 0-glycosylated serine which will result in 
the same derivatives as phosphoserine [ 121. 
However, with prior enzymatic splitting off of a 
possible carbohydrate moiety the results will be 
unambiguous. No problems arise with phospho- 
serine-containing peptides if the phosphate is label- 
ed with 32P, the nature of the serine derivative 
therefore being known. Even if the peptide con- 
tains more than one serine residue there should be 
no problem in exact determination of the correct 
position of phosphoserine, since unmodified serine 
will be unaltered during the modification reaction. 
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